SEC Filings | Enanta Pharmaceuticals, Inc.

SEC Filings

Filing date	Form	Description	Filing Group	View
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0000908662-13-000137.pdf 0000908662-13-000137.rtf 0000908662-13-000137.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0000908662-13-000138.pdf 0000908662-13-000138.rtf 0000908662-13-000138.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0000908662-13-000139.pdf 0000908662-13-000139.rtf 0000908662-13-000139.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001012975-13-000118.pdf 0001012975-13-000118.rtf 0001012975-13-000118.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001012975-13-000119.pdf 0001012975-13-000119.rtf 0001012975-13-000119.xls
Mar 20, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-13-018091.pdf 0001181431-13-018091.rtf 0001181431-13-018091.xls
Mar 20, 2013	EFFECT	EFFECT	Other	View HTML 9999999995-13-000755.pdf 9999999995-13-000755.rtf 9999999995-13-000755.xls
Mar 19, 2013	CERTNAS	CERTNAS	Other	View HTML 9999999997-13-005871.pdf 9999999997-13-005871.rtf
Mar 18, 2013	CORRESP	CORRESP	Other	View HTML 0001193125-13-111524.pdf 0001193125-13-111524.rtf 0001193125-13-111524.xls
Mar 18, 2013	CORRESP	CORRESP	Other	View HTML 0001193125-13-111530.pdf 0001193125-13-111530.rtf 0001193125-13-111530.xls

Data provided by Kaleidoscope.

Print Page Print Page
Email Alerts Email Alerts
RSS Feeds RSS Feeds
Contact IR Contact IR